The section is comprised of nationally and internationally known faculty with expertise in all major types of autoimmune diseases including but not limited to: Lupus, Myositis, Systemic Sclerosis, Sarcoidosis, Rheumatology-Reproduction, Cancer Immunotherapy toxicities or Immune-related adverse events, Spondyloarthritis. While the Principal Investigator is primarily responsible for the overall design, conduct, and management of the clinical trial, the CRC1 works with the PI, department, sponsor, and institution to support, facilitate and coordinate the daily clinical trial activities and administration of the compliance, financial, personnel and other related aspects of the clinical study.